• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AZIYO BIOLOGICS, INC. CANGAROO ENVELOPE; MESH, SURGICAL-FTM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AZIYO BIOLOGICS, INC. CANGAROO ENVELOPE; MESH, SURGICAL-FTM Back to Search Results
Model Number CMCV-009-XLG
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Wound Dehiscence (1154); Hematoma (1884); Unspecified Infection (1930)
Date of Event 02/22/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No sample was returned for evaluation.Manufacturing review of the referenced lot number and respective device history record was conducted, showing that all units were quality released on 29-dec-2020 having met all internal qc acceptance requirements.There were no non-conformances associated with the manufacturing lot during the final packaging.Sterile subassembly lot review was also reviewed for potential issues impacting the quality of this product.This subassembly lot was released to component inventory on 1-jun-2020 having met all quality requirements including product sterility testing following eo sterilization, as well as internal bioburden and product pyrogen (lal) testing requirements.In lieu of a request for the oem supplier for a dhr review of the ecm material lots, it is noted that aziyo processes the non-sterile envelope materials by cutting, suturing, packaging, and sterilizing.It is noted that per the instructions for use (ifu - art-20662c) provided with the finished cangaroo envelope device, "hematoma" and "infection" are listed as potential complications associated with this procedure and device usage.The cause of the initial hematoma event was attributed by the physician's office to the patient's anticoagulopathy and was procedure-related.The wound dehiscence likely was caused by the pocket infection.Both the dehiscence and the infection may have been caused by the initial incision and drainage of the hematoma.
 
Event or Problem Description
On (b)(6) 2022, aziyo was notified by business partner boston scientific that a patient with a cied (cardiovascular implantable electronic device) and an aziyo biologics cangaroo envelope (model cmcv-009-xlg, lot number m20n1423579) implanted on (b)(6) 2021, presented with pocket infection and wound dehiscence.Dehiscence first noted on (b)(6) 2022 and device eventually protruded though the skin.The aziyo device was explanted with the removal of the cied on (b)(6) 2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CANGAROO ENVELOPE
Common Device Name
MESH, SURGICAL-FTM
Manufacturer (Section D)
AZIYO BIOLOGICS, INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer (Section G)
AZIYO BIOLOGICS, INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer Contact
michael hennick
1100 old ellis road
ste 1200
roswell, GA 30076
MDR Report Key13932745
Report Number3005619880-2022-00008
Device Sequence Number11734690
Product Code FTM
UDI-Device Identifier00859389005072
UDI-Public00859389005072
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K201313
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Distributor
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/06/2022
Device Model NumberCMCV-009-XLG
Device Lot NumberM20N1423
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/09/2022
Initial Report FDA Received Date03/28/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/29/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age81 YR
Patient SexMale
-
-